Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0001140361-18-015300

Director sold 5,000 shares at $31.93 ($159,642)

From the SEC's structured data for this filing

Trades in this filing

GLUCK FREDERICK W · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-03-26 Sale : show line 1 in the form −5,000 $31.93 $159,642 271,643 I
Open-market sales · 5,000 sh · avg $31.93 · $159,642
Loading xslF345X03/doc1.xml…